Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Kutschke

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|June 28, 2005
Compound efflux in Helicobacter pyloriAmy Kutschke, Boudewijn L M de Jonge
Antimicrobial Agents and Chemotherapy|June 17, 2015
Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureusSushmita D Lahiri, Amy Kutschke, Kathy McCormack, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacyBoudewijn L M de Jonge, Amy Kutschke, Joseph V Newman, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2013
Exploring the UDP pocket of LpxC through amino acid analogsMichael R Hale, Pamela Hill, Sushmita Lahiri, et al.
Journal of Medicinal Chemistry|October 7, 2014
Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterizationGregory S Basarab, Patrick Brassil, Peter Doig, et al.
Journal of Medicinal Chemistry|September 11, 2020
Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA GyraseGregory S Basarab, Peter Doig, Charles J Eyermann, et al.
Journal of Medicinal Chemistry|July 10, 2015
Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914)Gregory S Basarab, Peter Doig, Vincent Galullo, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeaeRichard A Alm, Sushmita D Lahiri, Amy Kutschke, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2015
Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated EfficacyAryun Kim, Amy Kutschke, David E Ehmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR developmentKerry E Murphy-Benenato, Lakshmaiah Gingipalli, P Ann Boriack-Sjodin, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|June 28, 2005
Compound efflux in Helicobacter pyloriAmy Kutschke, Boudewijn L M de Jonge
Antimicrobial Agents and Chemotherapy|June 17, 2015
Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureusSushmita D Lahiri, Amy Kutschke, Kathy McCormack, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacyBoudewijn L M de Jonge, Amy Kutschke, Joseph V Newman, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2013
Exploring the UDP pocket of LpxC through amino acid analogsMichael R Hale, Pamela Hill, Sushmita Lahiri, et al.
Journal of Medicinal Chemistry|October 7, 2014
Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterizationGregory S Basarab, Patrick Brassil, Peter Doig, et al.
Journal of Medicinal Chemistry|September 11, 2020
Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA GyraseGregory S Basarab, Peter Doig, Charles J Eyermann, et al.
Journal of Medicinal Chemistry|July 10, 2015
Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914)Gregory S Basarab, Peter Doig, Vincent Galullo, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeaeRichard A Alm, Sushmita D Lahiri, Amy Kutschke, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2015
Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated EfficacyAryun Kim, Amy Kutschke, David E Ehmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR developmentKerry E Murphy-Benenato, Lakshmaiah Gingipalli, P Ann Boriack-Sjodin, et al.
Pageof 2